2Kaunitz AM. Injectable contraception: New and existing options. Obstet Gynecol Clin North Am, 2000, 27:741-780
3Jain JK, Ota F, Mishell DR. Comparison of ovarian follicular activity during treatment with a monthly injectable contraceptive and a low-dose oral contraceptive. Contraception, 2000, 61(3):195-198
4Clark MK, Sowers M, Levy BT, et al. Magnitude and variability of sequential estradiol and progesterone concentrations in women using depot medroxyprogesterone acetate for contraception. Fertil Steril, 2001,75(5): 871-877
5Petta CA, Hays M, Brache V, et al. Delayed first injection of the once-a-month injectable contraceptive containing 25 mg of medroxy-progesterone acetate and 5 mg of E(2)-cypionate: effects on ovarian function. Fertil Steril, 2001, 75(4): 744-748
6Bahamondes L, Lavin P, Ojeda G, et al. Return of fertility after dis-continuation of the once-a-month injectable contraceptive Cyclofem. Contraception, 1997,55:307-310
7Templeman CL, Cook V, Goldsmith J, et al. Postpartum contraceptive use among adolescent mothers. Obstet Gynecol, 2000, 95:770-776
8Taneepanichskul S, Reinprayoon D, Phaosavadi S. DMPA use above the age of 35 in Thai women. Contraception, 2000, 61(4): 281-282
9Chotnopparatpattara P, Taneepanichskul S. Use of depot medroxy-progesterone acetate in Thai adolescents. Contraception, 2000, 62(3): 137-140
10Hellerstedt WL, Story M. Adolescent satisfaction with postpartum contraception and body weight concerns. J Adolesc Health, 1998,22:445-452
